Healthtech Startups

Paceline is a consumer app that connects to fitness and health devices and apps (such as Apple Health, Garmin, Oura, and WHOOP) to combine a user's activity and health data into a single score that measures consistency. Users earn Pacepoints for steady healthy habits and unlock rewards from partner brands that support healthy living.

8 investors

Pelago is a virtual clinic that partners with employers and health plans to provide substance use disorder treatment and management services. The platform offers individual and discreet treatment for individuals struggling with substance misuse, from unhealthy habits to clinical substance use disorders.

8 investors

Peppy provides employer-sponsored digital health support delivered by in-house clinicians across areas such as menopause, fertility, men's health, pregnancy and lifestyle care. It serves employers looking to offer specialised, evidence-based healthcare to their staff.

8 investors

PhotoniCare develops OtoSight, an FDA-cleared optical coherence tomography device for non-invasive assessment and monitoring of middle ear infections in healthcare facilities. The technology is designed for physicians treating ear-related conditions and offers improved accuracy over traditional otoscope methods.

8 investors

PicnicHealth aggregates medical records from multiple sources and provides patients with centralized access to their health data along with AI-powered tools to understand and manage their medical information and chronic conditions.

8 investors

Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT. The system is built for hospitals and health systems to increase surgical capacity, standardize performance, and support clinical training through an AI foundation model trained on data from hundreds of surgeons.

8 investors

Rebellyous develops plant-based chicken nuggets and proprietary manufacturing systems designed to enable efficient, clean food production with improved working conditions. The company serves consumers seeking plant-based alternatives and operates in the alternative protein and food technology space.

8 investors

Rezilient Health provides primary and specialty care to employers and their families through a combination of in-person CloudClinics and telehealth services for a single flat fee. The company serves employers looking for an alternative to traditional health insurance with a focus on delivering accessible, coordinated care.

8 investors

SafeRide Health provides non-emergency medical transportation (NEMT) through a technology platform and a nationwide network of transport and rideshare providers, connecting patients — largely Medicare Advantage and Medicaid members — to healthcare appointments. It serves health plans, care providers, and patients across the 48 contiguous U.S. states with pre-scheduled and on-demand rides, ride tracking, and fleet management tools.

8 investors

Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.

8 investors

Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind. The company's device is under clinical investigation, including studies funded by the U.S. Department of Defense related to PTSD.

8 investors

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs. The company applies this "neuroimmune modulation" approach to autoimmune disease care.

8 investors

Sonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.

8 investors

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases. The company uses proprietary platform technologies to create targeted and durable Treg cell therapies.

8 investors

Summer Health provides text-based, on-demand pediatric care that connects parents with doctors within minutes for their children's non-scheduled health needs. The service targets busy parents in the United States seeking a convenient alternative to after-hours urgent care and emergency room visits.

8 investors

Tia is a healthcare platform that coordinates patient care by connecting care providers, clinical support, and care coordinators to manage appointments, prescriptions, billing, and procedures.

8 investors

Trial Library operates an AI-native platform that integrates clinical trials into routine care, activating providers, identifying eligible patients, and guiding them through the trial lifecycle. It connects health systems, biopharma sponsors, and payers/employers into a coordinated research network across the United States.

8 investors

Uptime Health provides operational tools and preventive maintenance plans to healthcare practices to reduce downtime and ensure regulatory compliance.

8 investors

Viz.ai uses artificial intelligence to accelerate care coordination in healthcare settings, reducing delays between patients and life-saving treatments. The company transforms clinical workflows to improve patient outcomes.

8 investors

Yuvo Health provides software and business services to help community health centers operate more effectively within value-based care models. The company works with Federally Qualified Health Centers (FQHCs) to improve financial sustainability, care quality, and patient reach across community markets.

8 investors

9amHealth provides virtual care for cardiometabolic conditions, offering weight management, diabetes care, and heart health treatment that combines prescription medication (including GLP-1s), lifestyle coaching, and lab testing. Care is delivered via telemedicine by a team of obesity specialists, pharmacists, dietitians, and behavioral health experts.

7 investors

Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis. The company is a clinical-stage biopharmaceutical firm running Phase 2/3 trials of its immunology treatments.

7 investors

Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology. Its lead candidate, ADCX-020, is being evaluated in a Phase 1 study in patients with advanced solid tumors.

7 investors

Akero develops engineered protein therapies for metabolic diseases, particularly MASH (metabolic dysfunction-associated steatohepatitis) and other conditions with high unmet medical need. The company's lead candidate, efruxifermin, is in phase 3 clinical trials for liver disease treatment.

7 investors